Associate Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School
Nephrology
Dr. Sushrut S. Waikar, MD
|
|
Give Review
Doctor Sushrut S. Waikar, MD is an expert in the field of Nephrology. He graduated from Yale University School of Medicine. Yale University School of Medicine is one of the top medical schools in the US. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care Sushrut Waikar is a published doctor and has 33 publications published. The lastest was: 'Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.
- Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients.
- Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.
- Electronic Health Record Patient Portals in CKD and Hypertension Management: Meaningfully Used?
- The Usefulness of Diagnostic Testing in the Initial Evaluation of Chronic Kidney Disease.
- Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium.
- Increased plasma catalytic iron in patients may mediate acute kidney injury and death following cardiac surgery.
- Reductions in Red Blood Cell 2,3-Diphosphoglycerate Concentration during Continuous Renal Replacment Therapy.
- Reply: active and native vitamin d in critical illness.
- Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.
- Plasma Catalytic Iron, AKI, and Death among Critically Ill Patients.
- Randomized Controlled Trial of Calcitriol in Severe Sepsis.
- In response to "Association of serum sodium with morbidity and mortality in hospitalized patients undergoing major orthopedic surgery"
- Optimal Dialysate Sodium-What is the Evidence?
- Association of serum sodium with morbidity and mortality in hospitalized patients undergoing major orthopedic surgery.
- Erythropoiesis-stimulating Agent Use among Patients with Lupus Nephritis Approaching End-stage Renal Disease.
- Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation.
- Incidence, Outcomes, and Comparisons across Definitions of AKI in Hospitalized Individuals.
- Imperfect gold standards for biomarker evaluation.
- A Risk Prediction Score for Kidney Failure or Mortality in Rhabdomyolysis.
- Vitamin D metabolism and action in human marrow stromal cells: effects of chronic kidney disease.
- Biomarkers in nephrology: Core Curriculum 2013.
- Relationship between the prognostic expectations of seriously ill patients undergoing hemodialysis and their nephrologists.
- Plasma FGF23 levels increase rapidly after acute kidney injury.
- Dysregulated Mineral Metabolism in Patients with Acute Kidney Injury and Risk of Adverse Outcomes.
- Preoperative statin use and postoperative acute kidney injury.
- Association of Smoking with Cardiovascular and Infection-Related Morbidity and Mortality in Chronic Hemodialysis.
- Fibrinogen Excretion in the Urine and Immunoreactivity in the Kidney Serves as a Translational Biomarker for Acute Kidney Injury.
- Expression, circulation and excretion profile of microRNA-21, -155, and -18a following acute kidney injury.
- FGF-23 Levels in Patients with AKI and Risk of Adverse Outcomes.
- Creatinine kinetics and the definition of acute kidney injury.
- Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury.
Schools
Yale University School Of Medicine
Brigham and WomensMgh
Doctors Specialties
- Nephrology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
UCSF -
Yale University School of Medicine
Hospital
-
Massachusetts General Hospital -
Brigham and Women's Hospital -
Brigham and Women's Faulkner Hospital
Drug Facts
| NPI NUMBER | 1801879150 | |
| NPPES Provider LastName | WAIKAR | |
| NPPES Provider FirstName | SUSHRUT | |
| NPPES Provider ZIPCode | 021156110 | |
| NPPES Provider State | MA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 77.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801879150 |
| Last Name Of The Provider | WAIKAR |
| First Name Of The Provider | SUSHRUT |
| View All |
Similar Doctors
|
|
Dr. Nina Tolkoff-Rubin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis A. Ausiello, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. James S. Kaufman, MD |
|
|
Dr. Karandeep Singh, MD |
|
|
Dr. Nelson B. Goes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie Lin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kambiz Zandi-Nejad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ogo I. Egbuna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel E. Weiner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ian R. Rifkin, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David J. Salant, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Madhumathi Rao, MD
This Doctor is OpenDoctor Recommended.
|